You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-IL-8

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Sars-CoV2, Hematological Malignancy Trial in New York (BMS-986253)

Terminated
  • Solid Tumor
  • +2 more
  • New York, New York
    Columbia University Irving Medical Center
Nov 18, 2021

NSCLC, Hepatocellular Carcinoma Trial in New York (Nivolumab, BMS-813160, BMS-986253)

Recruiting
  • Non-small Cell Lung Cancer
  • Hepatocellular Carcinoma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 14, 2021

Colon Carcinoma Trial in Netherlands (Nivolumab, Ipilimumab, Celecoxib 200mg)

Recruiting
  • Colon Carcinoma
  • Amsterdam, Netherlands
  • +5 more
Jan 23, 2023

Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
  • +2 more
  • Beijing, China
  • +2 more
Apr 26, 2022

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • TransCon IL-2 β/γ
  • +4 more
  • Boston, Massachusetts
  • +7 more
Nov 16, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 2, 2022

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 30, 2022

Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)

Recruiting
  • Non-Hodgkin Lymphoma
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jan 13, 2023

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Metastatic Uveal Melanoma
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Severe Prednisone Dependent Eosinophilic Asthma Trial in Hamilton (Benralizumab, Placebo)

Recruiting
  • Severe Prednisone Dependent Eosinophilic Asthma
  • Benralizumab
  • Placebo
  • Hamilton, Ontario, Canada
    Firestone Institute for Respiratory Health, Research - St. Josep
Sep 6, 2021

Crohn Disease Trial in Calgary (TNFa Antagonist - Infliximab, TNFa Antagonist - Adalimumab, Anti-IL12/23 or anti-IL23 -

Not yet recruiting
  • Crohn Disease
  • TNFa Antagonist - Infliximab
  • +5 more
  • Calgary, Alberta, Canada
    University of Calgary
Jun 22, 2023

PCO Trial in Peshawar (OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD), Metformin (1000 mg Twice a day))

Recruiting
  • PCO
  • OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD)
  • Metformin (1000 mg Twice a day)
  • Peshawar, Khyber Pakhtunkhwa, Pakistan
    Gynecology and Obstetric, Hayatabad Medical Complex
Jul 19, 2023

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Siltuximab
  • Spartalizumab
  • Atlanta, Georgia
  • +2 more
Feb 1, 2022

Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

Not yet recruiting
  • Esophagus Cancer
  • +4 more
  • Intravenous injection of P-IL-2
  • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
  • (no location specified)
Apr 24, 2023

Acute Gout Trial in Wuhan, Linyi, Shanghai (Recombinant Anti-IL-1ß Humanized Monoclonal Antibody Injection 100 mg (phase Ib),

Recruiting
  • Acute Gout
  • Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 100 mg (phase Ib)
  • +6 more
  • Wuhan, Hubei, China
  • +2 more
Oct 17, 2022

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma Trial

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +10 more
  • Antineoplastic Immune Cell
  • +4 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Aug 12, 2022

Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

Active, not recruiting
  • Metastatic Melanoma
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Psoriasis Trial in Shanghai, Kunming (Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection, Placebo)

Active, not recruiting
  • Psoriasis
  • Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection
  • Placebo
  • Shanghai, Shanghai, China
  • +2 more
Nov 7, 2022

Non-Eosinophilic Biological Effects of IL-5

Not yet recruiting
  • Asthma
    • (no location specified)
    Sep 6, 2023

    Axial Spondyloarthritis Trial in Nîmes, Montpellier, Tours (Daily dietary supplementation with Fibruline, Anti-IL-17 therapy)

    Recruiting
    • Axial Spondyloarthritis
    • Daily dietary supplementation with Fibruline
    • Anti-IL-17 therapy
    • Nîmes, Gard, France
    • +2 more
    Apr 19, 2023

    PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Subclinical hypothyroïdism, Hypothalamic-Pituitary-Gonadal Axis

    Not yet recruiting
    • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
    • +2 more
    • Measurement and comparison of leucocytosis and concentrations of CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha in both study arms
    • +2 more
    • Kraków, Poland
      Jagiellonian University Medical College, Department of Gynecolog
    Apr 29, 2023

    Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

    Not yet recruiting
    • Head and Neck Neoplasms
    • TransCon TLR7/8 Agonist
    • +2 more
    • (no location specified)
    Aug 4, 2023

    NSCLC Trial (Dupilumab, Cemiplimab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Dupilumab
    • Cemiplimab
    • (no location specified)
    Oct 12, 2023

    Psoriasis Trial in Shanghai (608 Q2W, 608 Q4W, Placebo)

    Not yet recruiting
    • Psoriasis
    • 608 Q2W
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Huanshan Hospital Fudan University
    Sep 8, 2022

    Periodontitis Trial in Rize (biochemical analysis)

    Completed
    • Periodontitis
    • biochemical analysis
    • Rize, Turkey
      Recep Tayyip Erdogan University
    Oct 18, 2023